Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2025-12-28 @ 7:38 PM
Study NCT ID:
NCT01817868
Status:
COMPLETED
Last Update Posted:
2020-05-27
First Post:
2013-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-23
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-12
First Submit QC Date:
None
Study First Post Date:
2013-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-22
Last Update Post Date:
2020-05-27
Last Update Post Date Type:
ACTUAL